Soc. Generale Bonus Zert MRK 27.0.../ DE000SV4G3X8 /
5/23/2024 11:11:42 AM | Chg.+2.060 | Bid11:44:50 AM | Ask11:44:50 AM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
204.530EUR | +1.02% | 204.300 Bid Size: 1,000 |
204.410 Ask Size: 1,000 |
MERCK KGAA O.N. | - EUR | 9/27/2024 | Call |
GlobeNewswire
5/22
Medicenna to Present Clinical Update on the MDNA11 ABILITY-1 Trial at the Upcoming Sachs 10th Annual...
GlobeNewswire
5/7
CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
GlobeNewswire
5/6
Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Person...
GlobeNewswire
3/4
C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...
GlobeNewswire
12/21/2023
Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...
GlobeNewswire
12/14/2023
ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...
GlobeNewswire
10/17/2023
ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA